• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

YAP 介导的非酒精性脂肪性肝病发病机制。

Pathogenesis of non-alcoholic fatty liver disease mediated by YAP.

机构信息

Laboratory of Animal Disease Model, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu, 611130, Sichuan, China.

Key Laboratory of Animal Disease and Human Health of Sichuan Province, College of Veterinary Medicine, Sichuan Agricultural University, Ya'an, 625014, Sichuan, China.

出版信息

Hepatol Int. 2018 Jan;12(1):26-36. doi: 10.1007/s12072-017-9841-y. Epub 2018 Jan 12.

DOI:10.1007/s12072-017-9841-y
PMID:29330836
Abstract

OBJECTIVE

This study aimed to investigate the mechanism of the interaction between Yes-associated protein (YAP) and transforming growth factor-β (TGF-β)/Smad signaling pathways in the development of non-alcoholic fatty liver disease (NAFLD).

METHODS

Serum samples of monkeys with biopsy-proven NAFLD and healthy normal monkeys were used to measure fasting plasma glucose (FPG), low-density lipoprotein (LDL), high-density lipoprotein (HDL), triglyceride (TG) and albumin (ALB) with the BECKMAN CX5 PRO. Hematoxylin-eosin staining (H&E) was used for pathologic analysis, Masson trichrome staining was used to assess for fibrosis staging, and Oil Red O staining was used to detect lipid droplet deposition. According to an NAFLD activity score of < 4 points and > 4 points, the samples were divided into groups: the steatosis group and fibrosing NASH group. Furthermore, monkeys with a fibrosis stage < 2 were assigned to the mild fibrosis group, while monkeys with fibrosis stage ≥ 2 were assigned to the significant fibrosis group. Moreover, the fibrosis stage was subdivided as follows: stages 1a, 1c and 2-3. Immunohistochemistry and real-time quantitative PCR were used to quantify protein and gene expression, respectively.

RESULTS

In the present study, 54 monkeys with NAFLD and 23 normal monkeys were recruited. Serum FPG and TG levels were higher in fibrosing NASH monkeys compared with simple steatosis and normal monkeys, and differences between simple steatosis and normal monkeys were not statistically significant (p > 0.05). YAP increased in NAFLD, which mainly localized in the nuclei of hepatocytes, perivascular cells and bile duct cells; the accumulation of YAP correlated with the severity of hepatocyte injury. Compared with normal monkeys, the expression of TGF-β, α-smooth muscle actin (α-SMA), Drosophila mothers against decapentaplegic protein 3 (Smad3) and connective tissue growth factor (CTGF) in the liver of simple steatosis monkeys significantly increased (p < 0.01). Compared with simple steatosis monkeys, the expression of TGF-β, α-SMA, Smad3 and CTGF in fibrosing NASH significantly increased (p < 0.01). However, the expression of Drosophila mothers against decapentaplegic protein 7 (Smad7) in the liver of fibrosing NASH monkeys significantly decreased (p < 0.01). With the severity of liver fibrosis, the expression of TGF-β, α-SMA, Smad3 and CTGF gradually increased, and the difference was statistically significant (p < 0.01). However, there was no significant difference in the expression of Smad3 between fibrosis stage 1a and 1c. Compared with normal monkeys, the expression of Smad7 in the liver of monkeys with fibrosis significantly decreased (p < 0.01), but was significantly higher at fibrosis stage 1c than at fibrosis stage 1a and 2.

CONCLUSION

The YAP and TGF-β signaling pathways and the interaction between them promote the development and progression of NAFLD.

摘要

目的

本研究旨在探讨 Yes 相关蛋白(YAP)与转化生长因子-β(TGF-β)/Smad 信号通路在非酒精性脂肪性肝病(NAFLD)发展中的相互作用机制。

方法

采用贝克曼 CX5 PRO 检测活检证实的 NAFLD 猴和健康正常猴的血清样本中的空腹血糖(FPG)、低密度脂蛋白(LDL)、高密度脂蛋白(HDL)、甘油三酯(TG)和白蛋白(ALB)。苏木精-伊红(H&E)染色用于病理分析,Masson 三色染色用于评估纤维化分期,油红 O 染色用于检测脂质滴沉积。根据 NAFLD 活动评分<4 分和>4 分,将样本分为两组:脂肪变性组和纤维化 NASH 组。此外,将纤维化分期<2 的猴分为轻度纤维化组,纤维化分期≥2 的猴分为显著纤维化组。此外,纤维化分期进一步分为 1a、1c 和 2-3 期。免疫组织化学和实时定量 PCR 分别用于定量蛋白和基因表达。

结果

本研究共纳入 54 只 NAFLD 猴和 23 只正常猴。与单纯脂肪变性和正常猴相比,纤维化 NASH 猴的血清 FPG 和 TG 水平升高,而单纯脂肪变性和正常猴之间的差异无统计学意义(p>0.05)。YAP 在 NAFLD 中增加,主要定位于肝细胞、血管周细胞和胆管细胞的核内;YAP 的积累与肝细胞损伤的严重程度相关。与正常猴相比,单纯脂肪变性猴肝组织中 TGF-β、α-平滑肌肌动蛋白(α-SMA)、果蝇母源抑制物 Decapentaplegic 蛋白 3(Smad3)和结缔组织生长因子(CTGF)的表达显著增加(p<0.01)。与单纯脂肪变性猴相比,纤维化 NASH 猴 TGF-β、α-SMA、Smad3 和 CTGF 的表达显著增加(p<0.01)。然而,纤维化 NASH 猴肝组织中果蝇母源抑制物 Decapentaplegic 蛋白 7(Smad7)的表达显著降低(p<0.01)。随着肝纤维化程度的加重,TGF-β、α-SMA、Smad3 和 CTGF 的表达逐渐增加,差异具有统计学意义(p<0.01)。然而,Smad3 在纤维化 1a 期和 1c 期之间的表达差异无统计学意义。与正常猴相比,纤维化猴肝组织中 Smad7 的表达显著降低(p<0.01),但在纤维化 1c 期明显高于纤维化 1a 期和 2 期。

结论

YAP 和 TGF-β 信号通路及其相互作用促进了 NAFLD 的发生和发展。

相似文献

1
Pathogenesis of non-alcoholic fatty liver disease mediated by YAP.YAP 介导的非酒精性脂肪性肝病发病机制。
Hepatol Int. 2018 Jan;12(1):26-36. doi: 10.1007/s12072-017-9841-y. Epub 2018 Jan 12.
2
Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients.氧化型低密度脂蛋白抗体/高密度脂蛋白胆固醇比值与晚期非酒精性脂肪性肝病瘦患者有关。
J Gastroenterol Hepatol. 2016 Sep;31(9):1611-8. doi: 10.1111/jgh.13335.
3
Accumulation of duct cells with activated YAP parallels fibrosis progression in non-alcoholic fatty liver disease.在非酒精性脂肪性肝病中,具有激活的YAP的导管细胞积累与纤维化进展平行。
J Hepatol. 2015 Oct;63(4):962-70. doi: 10.1016/j.jhep.2015.05.031. Epub 2015 Jun 10.
4
Calycosin attenuates triglyceride accumulation and hepatic fibrosis in murine model of non-alcoholic steatohepatitis via activating farnesoid X receptor.毛蕊异黄酮通过激活法尼醇 X 受体减轻非酒精性脂肪性肝炎小鼠模型的甘油三酯积累和肝纤维化。
Phytomedicine. 2017 Feb 15;25:83-92. doi: 10.1016/j.phymed.2016.12.006. Epub 2016 Dec 13.
5
Effects of RNA interference targeting transforming growth factor-beta 1 on immune hepatic fibrosis induced by Concanavalin A in mice.靶向转化生长因子-β1的RNA干扰对刀豆蛋白A诱导的小鼠免疫性肝纤维化的影响
Hepatobiliary Pancreat Dis Int. 2009 Jun;8(3):300-8.
6
Ghrelin Attenuates Liver Fibrosis through Regulation of TGF-β1 Expression and Autophagy.胃饥饿素通过调节转化生长因子-β1表达和自噬减轻肝纤维化。
Int J Mol Sci. 2015 Sep 10;16(9):21911-30. doi: 10.3390/ijms160921911.
7
Histone deacetylase inhibitor suberoylanilide hydroxamic acid alleviates liver fibrosis by suppressing the transforming growth factor-β1 signal pathway.组蛋白去乙酰化酶抑制剂丁酸钠通过抑制转化生长因子-β1 信号通路缓解肝纤维化。
Hepatobiliary Pancreat Dis Int. 2018 Oct;17(5):423-429. doi: 10.1016/j.hbpd.2018.09.013. Epub 2018 Sep 15.
8
Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways.六味五灵片通过调节 TGF-β/Smad 和 NF-κB 信号通路减轻 BDL 诱导的肝纤维化。
J Ethnopharmacol. 2018 Jan 10;210:232-241. doi: 10.1016/j.jep.2017.08.029. Epub 2017 Aug 31.
9
Regulatory effect of a Chinese herbal medicine formula on non-alcoholic fatty liver disease.中药方剂对非酒精性脂肪肝的调控作用。
World J Gastroenterol. 2019 Sep 14;25(34):5105-5119. doi: 10.3748/wjg.v25.i34.5105.
10
[Establishment of a complex alcoholic liver fibrosis mouse model and investigation of OPN and TGF-beta1 hepatic expression].[复合性酒精性肝纤维化小鼠模型的建立及骨桥蛋白和转化生长因子-β1肝脏表达的研究]
Zhonghua Gan Zang Bing Za Zhi. 2013 Mar;21(3):207-12.

引用本文的文献

1
Dual signaling pathways of TGF-β superfamily cytokines in hepatocytes: balancing liver homeostasis and disease progression.肝细胞中转化生长因子-β超家族细胞因子的双信号通路:平衡肝脏内稳态与疾病进展
Front Pharmacol. 2025 Apr 7;16:1580500. doi: 10.3389/fphar.2025.1580500. eCollection 2025.
2
Smad4 deficiency in hepatocytes attenuates NAFLD progression via inhibition of lipogenesis and macrophage polarization.肝细胞中Smad4的缺乏通过抑制脂肪生成和巨噬细胞极化来减轻非酒精性脂肪性肝病的进展。
Cell Death Dis. 2025 Jan 31;16(1):58. doi: 10.1038/s41419-025-07376-8.
3
TGF-β/Smad signaling pathway in fatty liver disease: a case-control study.

本文引用的文献

1
YAP/TAZ Are Mechanoregulators of TGF--Smad Signaling and Renal Fibrogenesis.YAP/TAZ是转化生长因子-β-Smad信号传导和肾纤维化的机械调节因子。
J Am Soc Nephrol. 2016 Oct;27(10):3117-3128. doi: 10.1681/ASN.2015050499. Epub 2016 Mar 9.
2
Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.全球非酒精性脂肪性肝病流行病学——患病率、发病率和结局的荟萃分析评估。
Hepatology. 2016 Jul;64(1):73-84. doi: 10.1002/hep.28431. Epub 2016 Feb 22.
3
Accumulation of duct cells with activated YAP parallels fibrosis progression in non-alcoholic fatty liver disease.
脂肪性肝病中 TGF-β/Smad 信号通路:病例对照研究。
Mol Biol Rep. 2024 Oct 1;51(1):1031. doi: 10.1007/s11033-024-09973-w.
4
Hepatocyte-Specific Knockout Maintained the Liver Homeostasis of Lipid Metabolism in Mice.肝细胞特异性敲除维持了小鼠肝脏脂质代谢的稳态。
Diabetes Metab Syndr Obes. 2024 Aug 27;17:3197-3214. doi: 10.2147/DMSO.S472778. eCollection 2024.
5
Interplay between YAP/TAZ and metabolic dysfunction-associated steatotic liver disease progression.YAP/TAZ 与代谢相关脂肪性肝病进展的相互作用。
Arch Pharm Res. 2024 Jun;47(6):558-570. doi: 10.1007/s12272-024-01501-5. Epub 2024 Jun 14.
6
Production, Exacerbating Effect, and EV-Mediated Transcription of Hepatic CCN2 in NASH: Implications for Diagnosis and Therapy of NASH Fibrosis.在 NASH 中 CCN2 的产生、加重作用和 EV 介导的转录:对 NASH 纤维化的诊断和治疗的影响。
Int J Mol Sci. 2023 Aug 15;24(16):12823. doi: 10.3390/ijms241612823.
7
Extracellular-Matrix Mechanics Regulate the Ocular Physiological and Pathological Activities.细胞外基质力学调节眼部生理和病理活动。
J Ophthalmol. 2023 Jul 22;2023:7626920. doi: 10.1155/2023/7626920. eCollection 2023.
8
YES-associated protein-regulated Smad7 worsen epithelial barrier injury of chronic sinusitis with nasal polyps.YES 相关蛋白调节的 Smad7 加重慢性鼻-鼻窦炎伴鼻息肉患者的上皮屏障损伤。
Immun Inflamm Dis. 2023 Jun;11(6):e907. doi: 10.1002/iid3.907.
9
Mechanosensation to inflammation: Roles for YAP/TAZ in innate immune cells.机械感知与炎症:YAP/TAZ 在先天免疫细胞中的作用。
Sci Signal. 2023 May 2;16(783):eadc9656. doi: 10.1126/scisignal.adc9656.
10
MgIG Attenuates Oxaliplatin-induced Hepatotoxicity through Suppression of Connexin 43 in Hepatic Stellate Cells.MgIG通过抑制肝星状细胞中的连接蛋白43减轻奥沙利铂诱导的肝毒性。
J Clin Transl Hepatol. 2023 Jun 28;11(3):584-594. doi: 10.14218/JCTH.2022.00048. Epub 2022 Dec 5.
在非酒精性脂肪性肝病中,具有激活的YAP的导管细胞积累与纤维化进展平行。
J Hepatol. 2015 Oct;63(4):962-70. doi: 10.1016/j.jhep.2015.05.031. Epub 2015 Jun 10.
4
Crosstalk between Hippo and TGFβ: Subcellular Localization of YAP/TAZ/Smad Complexes.Hippo与TGFβ之间的相互作用:YAP/TAZ/Smad复合体的亚细胞定位
J Mol Biol. 2015 Oct 23;427(21):3407-15. doi: 10.1016/j.jmb.2015.04.015. Epub 2015 May 1.
5
The Hippo pathway effector YAP controls mouse hepatic stellate cell activation.Hippo 通路效应物 YAP 控制小鼠肝星状细胞的激活。
J Hepatol. 2015 Sep;63(3):679-88. doi: 10.1016/j.jhep.2015.04.011. Epub 2015 Apr 20.
6
Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis.通过YAP和TAZ的机械信号传导驱动成纤维细胞活化和纤维化。
Am J Physiol Lung Cell Mol Physiol. 2015 Feb 15;308(4):L344-57. doi: 10.1152/ajplung.00300.2014. Epub 2014 Dec 12.
7
Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up.纤维化分期是经过长达 33 年随访后,NAFLD 患者疾病特异性死亡率的最强预测因子。
Hepatology. 2015 May;61(5):1547-54. doi: 10.1002/hep.27368. Epub 2015 Mar 23.
8
Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology.命运追踪揭示了肝星状细胞是肝纤维化的主要贡献者,而与病因无关。
Nat Commun. 2013;4:2823. doi: 10.1038/ncomms3823.
9
Origin and function of myofibroblasts in kidney fibrosis.肌成纤维细胞在肾纤维化中的起源和功能。
Nat Med. 2013 Aug;19(8):1047-53. doi: 10.1038/nm.3218. Epub 2013 Jun 30.
10
The Hippo pathway and human cancer.Hippo 通路与人类癌症。
Nat Rev Cancer. 2013 Apr;13(4):246-57. doi: 10.1038/nrc3458. Epub 2013 Mar 7.